TY  - GEN
AU  - Stockfleth,E
TI  - Lmax and imiquimod 3.75%: the new standard in AK management
SN  - 1468-3083
PY  - 2015///0720
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Aminoquinolines
KW  - Humans
KW  - Imiquimod
KW  - Keratosis, Actinic
KW  - drug therapy
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1111/jdv.12824
ER  -